Data as of Mar 11
| +0.36 / +3.59%|
The 1 analysts offering 12-month price forecasts for Evoke Pharma Inc have a median target of 60.00, with a high estimate of 60.00 and a low estimate of 60.00. The median estimate represents a +477.48% increase from the last price of 10.39.
The current consensus among 1 polled investment analysts is to Buy stock in Evoke Pharma Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.